ストックスクリーナーアプリを入手
20.47
3.12%
0.62
アフターアワーズ：
20.47
前日終値:
$19.85
開ける：
$19.99
24時間の取引高:
813.49K
Relative Volume:
0.74
時価総額：
$947.03M
収益：
$82.71M
当期純損益:
$-102.24M
株価収益率:
-5.5777
EPS:
-3.67
ネットキャッシュフロー:
$-76.57M
1週間 パフォーマンス:
+7.91%
1か月 パフォーマンス:
+2.61%
6か月 パフォーマンス:
+75.86%
1年 パフォーマンス:
+66.97%
1日の値動き範囲:
$19.73
$20.72
1週間の範囲:
$19.00
$21.00
52週間の値動き範囲:
$3.42
$21.71
Urogen Pharma Ltd Stock (URGN) Company Profile
URGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
URGN
Urogen Pharma Ltd
|
20.47 | 918.34M | 82.71M | -102.24M | -76.57M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Urogen Pharma Ltd Stock (URGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2025-06-16 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-05-22 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-04-16 | 開始されました | Scotiabank | Sector Outperform |
| 2025-02-19 | 再開されました | Ladenburg Thalmann | Buy |
| 2024-08-22 | 開始されました | Guggenheim | Buy |
| 2023-02-08 | ダウングレード | Jefferies | Buy → Hold |
| 2022-04-27 | 開始されました | Berenberg | Buy |
| 2020-04-16 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-04-13 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-01-09 | 開始されました | National Securities | Neutral |
| 2019-05-30 | 開始されました | JP Morgan | Neutral |
| 2019-05-29 | 開始されました | Goldman | Neutral |
| 2019-01-29 | 開始されました | H.C. Wainwright | Buy |
| 2018-11-08 | 再開されました | Jefferies | Buy |
| 2018-04-04 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-01-02 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-11-15 | 繰り返されました | Oppenheimer | Outperform |
| 2017-11-15 | ダウングレード | Raymond James | Outperform → Mkt Perform |
すべてを表示
Urogen Pharma Ltd (URGN) 最新ニュース
Can UroGen Pharma Ltd. stock withstand economic slowdownCPI Data & Weekly Setup with High ROI Potential - newser.com
Using data tools to time your UroGen Pharma Ltd. exitTrade Ideas & Free Safe Entry Trade Signal Reports - newser.com
Does UroGen Pharma Ltd. show high probability of rebound2025 Key Highlights & Capital Protection Trading Alerts - newser.com
UroGen: Expect Rough Patch Before Strong Recovery In 2026 (NASDAQ:URGN) - Seeking Alpha
Is UroGen Pharma Ltd. stock bottoming outPortfolio Growth Summary & Community Verified Trade Signals - newser.com
How UroGen Pharma Ltd. stock reacts to job market dataJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com
Applying Elliott Wave Theory to UroGen Pharma Ltd.2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Can UroGen Pharma Ltd. stock resist sector downturnsJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Is UroGen Pharma Ltd. (UR8) stock undervalued after correctionMarket Weekly Review & Intraday High Probability Setup Alerts - newser.com
How UroGen Pharma Ltd. stock compares to industry benchmarks2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
What indicators show strength in UroGen Pharma Ltd.Gold Moves & Safe Capital Allocation Plans - newser.com
Published on: 2025-10-31 04:05:16 - newser.com
Why UroGen Pharma Ltd. (UR8) stock stays on buy listsWeekly Profit Report & Community Trade Idea Sharing - newser.com
Automated trading signals detected on UroGen Pharma Ltd.July 2025 Technicals & Verified Momentum Stock Alerts - newser.com
How UroGen Pharma Ltd. (UR8) stock behaves in tightening cyclesJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
What analysts say about UroGen Pharma Ltd stockPrice Volatility Patterns & High Return Stock Ideas - earlytimes.in
UroGen Pharma to Report Third Quarter 2025 Financial Results on Thursday, November 6th, 2025 - The Manila Times
Migdal Insurance & Financial Holdings Ltd. Reduces Position in Urogen Pharma $URGN - MarketBeat
Published on: 2025-10-30 00:50:10 - newser.com
UroGen Pharma Hits Day High with 9.46% Surge in Stock Price - Markets Mojo
Urogen Pharma (URGN) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance
Urogen Pharma (URGN) to Release Earnings on Wednesday - MarketBeat
Allianz Asset Management GmbH Invests $203,000 in Urogen Pharma $URGN - MarketBeat
Urogen Pharma (NASDAQ:URGN) Trading 10.1% HigherHere's What Happened - MarketBeat
Is UroGen Pharma Ltd. stock attractive for ETFs2025 Market WrapUp & Stock Market Timing Techniques - fcp.pa.gov.br
HC Wainwright Reaffirms Buy Rating for Urogen Pharma (NASDAQ:URGN) - MarketBeat
Urogen Pharma Ltd (URGN) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):